Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Acetazolamide

Known as: 2-acetylamino-1,3,4-Thiadiazole-5-sulfonamide, 5-acetylamino-1,3,4-Thiadiazole-2-sulfonamide, Acetazolamide [Chemical/Ingredient] 
A sulfonamide derivative with diuretic, antiglaucoma, and anticonvulsant properties. Acetazolamide is a non-competitive inhibitor of carbonic… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2008
Highly Cited
2008
The purpose of this study was to formulate topically effective controlled release ophthalmic acetazolamide liposomal formulations… 
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 4
Highly Cited
2007
Highly Cited
2007
Objectives –  To assess the efficacy of topiramate in the treatment of idiopathic intracranial hypertension (IIH) and to compare… 
Highly Cited
2006
Highly Cited
2006
  • S. Javaheri
  • American journal of respiratory and critical care…
  • 2006
  • Corpus ID: 45117160
RATIONALE Acetazolamide is a mild diuretic and a respiratory stimulant. It is used to treat periodic breathing at high altitude… 
Review
2006
Review
2006
  • table 1.1
  • table 1.2
  • table 1.3
  • table 1.4
  • figure 1.1
Highly Cited
2001
Highly Cited
2001
Background and Purpose— The importance of hemodynamic parameters for predicting outcome in patients with occlusive carotid… 
  • table 1
  • table 2
  • table 3
Review
1997
Review
1997
  • S. Lindskog
  • Pharmacology & therapeutics
  • 1997
  • Corpus ID: 25329287
Review
1989
Review
1989
High‐dose treatment with pilocarpine hydrochloride, a cholinergic muscarinic agonist, induces seizures in rodents following… 
Highly Cited
1976
Highly Cited
1967
Highly Cited
1967
  • table I
  • figure 2
  • table II
  • figure 1
  • figure 3
Highly Cited
1966
Highly Cited
1966
The availability at the National institutes of Heal th of a group of patients undergoing cerebrospinal fluid perfusion… 
  • table 3
  • figure 1